Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1979 Feb;38(1):40–44. doi: 10.1136/ard.38.1.40

Leucapheresis in severe rheumatoid arthritis.

J Tenenbaum, M B Urowitz, E C Keystone, I L Dwosh, J E Curtis
PMCID: PMC1000316  PMID: 434945

Abstract

Two patients with severe seropositive rheumatoid arthritis previously unresponsive to conventional therapy have been treated with leucapheresis. This technique involves continuous cell separation daily to remove primarily lymphocytes. Clinical improvement was recorded with the use of standard rheumatological measures of inflammation. It is concluded that leucapheresis may help in the management of severely active rheumatoid arthritis when conventional therapy has been unsuccessful.

Full text

PDF
40

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carr R. I., Hoffmann A. A., Harbeck R. J. Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLE. J Rheumatol. 1975 Jun;2(2):178–183. [PubMed] [Google Scholar]
  2. Clements P. J., Yu D. T., Levy J., Paulus H. E., Barnett E. V. Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis. Arthritis Rheum. 1974 Jul-Aug;17(4):347–353. doi: 10.1002/art.1780170403. [DOI] [PubMed] [Google Scholar]
  3. Curtis J. E., Hersh E. M., Freireich E. J. Leukapheresis therapy of chronic lymphocytic leukemia. Blood. 1972 Feb;39(2):163–175. [PubMed] [Google Scholar]
  4. Edelson R., Facktor M., Andrews A., Lutzner M., Schein P. Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis. N Engl J Med. 1974 Aug 8;291(6):293–294. doi: 10.1056/NEJM197408082910608. [DOI] [PubMed] [Google Scholar]
  5. Ellman L., Miller L., Rappeport J. Leukopheresis therapy of a hypereosinophilic disorder. JAMA. 1974 Nov 18;230(7):1004–1005. [PubMed] [Google Scholar]
  6. HARGRAVES M. M. Systemic lupus erythematosus and L. E. cell phenomenon. Postgrad Med. 1954 Sep;16(3):163–174. doi: 10.1080/00325481.1954.11711656. [DOI] [PubMed] [Google Scholar]
  7. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LANSBURY J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations. Arthritis Rheum. 1958 Dec;1(6):505–522. doi: 10.1002/art.1780010604. [DOI] [PubMed] [Google Scholar]
  9. Oon C. J., Hobbs J. R. Clinical applications of the continuous flow blood separator machine. Clin Exp Immunol. 1975 Apr;20(1):1–16. [PMC free article] [PubMed] [Google Scholar]
  10. PLOTZ C. M., SINGER J. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med. 1956 Dec;21(6):888–892. [PubMed] [Google Scholar]
  11. Pearson C. M., Paulus H. E., Machleder H. I. The role of the lymphocyte and its products in the propagation of joint disease. Ann N Y Acad Sci. 1975 Jun 13;256:150–168. doi: 10.1111/j.1749-6632.1975.tb36044.x. [DOI] [PubMed] [Google Scholar]
  12. Ross G. D., Rabellino E. M., Polley M. J., Grey H. M. Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest. 1973 Feb;52(2):377–385. doi: 10.1172/JCI107194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Savage O. Assessments in rheumatic disease. Measurements in rheumatoid arthritis. Proc R Soc Med. 1966;59 (Suppl):85–88. [PMC free article] [PubMed] [Google Scholar]
  14. Urowitz M. B., Gordon D. A., Smythe H. A., Pruzanski W., Ogryzio M. A. Azathioprine in rheumatoid arthritis. A double-blind, cross over study. Arthritis Rheum. 1973 May-Jun;16(3):411–418. doi: 10.1002/art.1780160319. [DOI] [PubMed] [Google Scholar]
  15. Veys E. M., Mielants H. Longterm evaluation of intermittent levamisole treatment in rheumatoid arthritis. J Rheumatol. 1977 Spring;4(1):27–34. [PubMed] [Google Scholar]
  16. Yu D. T., Peter J. B. Cellular immunological aspects of rheumatoid arthritis. Semin Arthritis Rheum. 1974 Fall;4(1):25–52. doi: 10.1016/0049-0172(74)90016-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES